The CSIR has reported a net profit of R40.62 million for the 2024/25 financial year. This hugely exceeded the targeted loss of R67.6 million, and is a testament to the growth and success the ...
Aspen Neuroscience’s cash reserves have been fertilized with a $115 million series C fundraise that will enrich the biotech’s ongoing trial of a regenerative cell therapy for Parkinson’s disease. The ...
SAN DIEGO, Nov. 20, 2025 /PRNewswire/ -- Aspen Neuroscience, Inc., a clinical-stage biotechnology company pioneering autologous regenerative therapies, today announced the closing of a $115 million ...
As the CSIR UGC NET December 2025 exam approaches on December 18, 2025, candidates across India are gearing up to compete for Junior Research Fellowship (JRF) and Assistant Professor eligibility in ...